Trial · NCT02318693
Results by group18
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 18 of 18
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in Mean Amplitude of Glycemic Excursions (MAGE) at Day 13 | Sitagliptin 50 mg | -18.5 | 95% Confidence Interval -30.0 to -7.1 | mg/dL | |
| Change From Baseline in Mean Amplitude of Glycemic Excursions (MAGE) at Day 13 | Glibenclamide 2.50 mg TDD | -9.7 | 95% Confidence Interval -21.1 to 1.6 | mg/dL | |
| Change From Baseline in the Standard Deviation of Blood Glucose Levels | Sitagliptin 50 mg | -10.2 | 95% Confidence Interval -14.4 to -6.0 | mg/dL | |
| Change From Baseline in the Standard Deviation of Blood Glucose Levels | Glibenclamide 2.50 mg TDD | -4.2 | 95% Confidence Interval -8.4 to -0.1 | mg/dL | |
| Change From Baseline in Maximum Incremental Postprandial Glucose Levels in Each Meal | Sitagliptin 50 mg | Breakfast | -24.8 | 95% Confidence Interval -34.1 to -15.6 | mg/dL |
| Change From Baseline in Maximum Incremental Postprandial Glucose Levels in Each Meal | Glibenclamide 2.50 mg TDD | Breakfast | -12.0 | 95% Confidence Interval -21.1 to -2.9 | mg/dL |
| Change From Baseline in Maximum Incremental Postprandial Glucose Levels in Each Meal | Sitagliptin 50 mg | Lunch | -13.2 | 95% Confidence Interval -24.0 to -2.3 | mg/dL |
| Change From Baseline in Maximum Incremental Postprandial Glucose Levels in Each Meal | Glibenclamide 2.50 mg TDD | Lunch | 1.2 | 95% Confidence Interval -9.6 to 11.9 | mg/dL |
| Change From Baseline in Maximum Incremental Postprandial Glucose Levels in Each Meal | Sitagliptin 50 mg | Dinner | -9.0 | 95% Confidence Interval -20.9 to 2.9 | mg/dL |
| Change From Baseline in Maximum Incremental Postprandial Glucose Levels in Each Meal | Glibenclamide 2.50 mg TDD | Dinner | -14.1 | 95% Confidence Interval -25.9 to -2.3 | mg/dL |
| Change From Baseline in 24-hour Mean Glucose Level | Sitagliptin 50 mg | -19.1 | 95% Confidence Interval -28.5 to -9.7 | mg/dL | |
| Change From Baseline in 24-hour Mean Glucose Level | Glibenclamide 2.50 mg TDD | -34.8 | 95% Confidence Interval -44.0 to -25.5 | mg/dL | |
| Change From Baseline in Percentage of Hypoglycemic Values (Glucose Sensor Readings: < 70, <60, <50 mg/dL) | Sitagliptin 50 mg | <70 mg/dL | -0.3 | 95% Confidence Interval -1.6 to 1.0 | Percent change |
| Change From Baseline in Percentage of Hypoglycemic Values (Glucose Sensor Readings: < 70, <60, <50 mg/dL) | Glibenclamide 2.50 mg TDD | <70 mg/dL | 0.8 | 95% Confidence Interval -0.5 to 2.1 | Percent change |
| Change From Baseline in Percentage of Hypoglycemic Values (Glucose Sensor Readings: < 70, <60, <50 mg/dL) | Sitagliptin 50 mg | <60 mg/dL | -0.4 | 95% Confidence Interval -1.3 to 0.5 | Percent change |
| Change From Baseline in Percentage of Hypoglycemic Values (Glucose Sensor Readings: < 70, <60, <50 mg/dL) | Glibenclamide 2.50 mg TDD | <60 mg/dL | 0.2 | 95% Confidence Interval -0.7 to 1.1 | Percent change |
| Change From Baseline in Percentage of Hypoglycemic Values (Glucose Sensor Readings: < 70, <60, <50 mg/dL) | Sitagliptin 50 mg | <50 mg/dL | -0.3 | 95% Confidence Interval -0.8 to 0.2 | Percent change |
| Change From Baseline in Percentage of Hypoglycemic Values (Glucose Sensor Readings: < 70, <60, <50 mg/dL) | Glibenclamide 2.50 mg TDD | <50 mg/dL | -0.3 | 95% Confidence Interval -0.7 to 0.2 | Percent change |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02318693/results